Pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), markers of microglial activation, and intestinal permeability indicators (e.g., zonulin, lipopolysaccharide-binding protein) are candidate biomarkers for the inflammatory component of PD. This evidence concerns the gene IL6 and Parkinson disease.